Bio Green Med Solution, Inc. (BGMS) is up 83.0% today. Here is some analysis on what might have caused this price movement.
Analysis: Shares appear to be reacting to the company’s announcement of a major business combination that would bring in a new operating business and substantially reshape BGMS’s ownership. The deal structure implies extreme dilution for current shareholders, but micro-cap traders often bid these “reverse merger” setups higher on the prospect of a new growth narrative and increased attention/liquidity.
Details:
Sources:
U.S. Securities and Exchange Commission, ADVFN, Stock Analysis
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$BGMS Hedge Fund Activity
We have seen 7 institutional investors add shares of $BGMS stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA SECURITIES, LLC removed 27,984 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $27,984
- DRW SECURITIES, LLC removed 24,857 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $24,857
- RENAISSANCE TECHNOLOGIES LLC added 23,500 shares (+104.0%) to their portfolio in Q1 2026, for an estimated $23,500
- CITADEL ADVISORS LLC added 22,051 shares (+inf%) to their portfolio in Q1 2026, for an estimated $22,051
- XTX TOPCO LTD added 21,872 shares (+inf%) to their portfolio in Q1 2026, for an estimated $21,872
- GEODE CAPITAL MANAGEMENT, LLC added 21,588 shares (+inf%) to their portfolio in Q1 2026, for an estimated $21,588
- UBS GROUP AG added 1,585 shares (+271.4%) to their portfolio in Q1 2026, for an estimated $1,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.